Analysis of Clinicopathological Features of the Echinoderm Microtubule-Associated Protein-Like-4-Anaplastic Lymphoma Kinase Fusion Gene in Chinese Patients With Advanced Non-Small-Cell Lung Cancer

Thoracic Cancer - Australia
doi 10.1111/1759-7714.12101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Clinical Challenges in Targeting Anaplastic Lymphoma Kinase in Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Correlation of Anaplastic Lymphoma Kinase Overexpression and the EML4-ALK Fusion Gene in Non-Small Cell Lung Cancer by Immunohistochemical Study

Biomedical Journal
Medicine
2012English

Alectinib in Untreated Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2017English

Are Anaplastic Lymphoma Kinase Gene Rearrangements in Non-Small Cell Lung Cancer Prognostic, Predictive, or Both?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Diagnostic Assays for Identification of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2012English

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

Expanding Anaplastic Lymphoma Kinase Therapeutic Indication to Early Stage Non-Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2019English

Anaplastic Lymphoma Kinase (ALK) Inhibitors for Second-Line Therapy of Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy